Article info
PDFResearch ethics
Quantitative aspects of informed consent: considering the dose response curve when estimating quantity of information
- Correspondence to: Professor N Lynöe Centre for Bioethics, LIME, Karolinska Institutet, Stockholm, Sweden; niels.lynoe{at}lime.ki.se
Citation
Quantitative aspects of informed consent: considering the dose response curve when estimating quantity of information
Publication history
- Received March 4, 2005
- Accepted March 14, 2005
- First published November 30, 2005.
Online issue publication
April 27, 2016
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2005 by the Journal of Medical Ethics
Other content recommended for you
- An empirical study on the preferred size of the participant information sheet in research
- Cross-sectional assessment of patient attitudes towards participation in clinical trials: does making results publicly available matter?
- Evaluating the impact of a SIMPlified LaYered consent process on recruitment of potential participants to the Staphylococcus aureus Network Adaptive Platform trial: study protocol for a multicentre pragmatic nested randomised clinical trial (SIMPLY-SNAP trial)
- Patients' perceptions of information provided in clinical trials
- Supporting positive experiences and sustained participation in clinical trials: looking beyond information provision
- Decision aids for randomised controlled trials: a qualitative exploration of stakeholders’ views
- Streamlining the Clinical Research Enterprise
- Return of participant-level clinical trial results to participants: pilot of a simplified centralised approach
- From protection to entitlement: selecting research subjects for early phase clinical trials involving breakthrough therapies
- Engaging African ancestry participants in SLE clinical trials